Glucagon-like peptide-1 receptor agonist treatment attributes important to injection-experienced patients with type 2 diabetes mellitus: a preference study in Germany and the United Kingdom
The community provides a welcoming environment where members can discuss treatment experiences, lifestyle changes, side effects, long-term health goals, and the everyday challenges and successes that often accompany a GLP-1 journey
This could further indicate a shift towards attempting to synthesize EGT in the mutant, given that histidine is a key biosynthetic precursor of EGT
32 Importantly, recently developed long-acting GLP-1 analogs have been demonstrated to target multiple brain nuclei, including the hypothalamus, thereby expanding the therapeutic potential of GLP-1-based interventions 36,46 (See Figure 1)
The results showed that Novo's drug, CagriSema, promoted slightly less weight loss than Zepbound at 84 weeks in the study a difference that puts the sales potential of the experimental treatment into question